OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Case with Schall Law Firm

Schall Law Firm, a national litigation firm focused on shareholder rights litigation, reminds investors of a class action lawsuit against Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX) for violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between October 11, 2022 and September 12, 2023, inclusive (the “Class Period”), are encouraged to contact the Firm before October 21, 2024.